Dr. Vincent Ma
Claim this profileUniversity of Wisconsin Carbone Cancer Center
Studies Skin Cancer
Studies Melanoma
8 reported clinical trials
15 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
Stage I
2Melanoma
Stage IV
BRAF positive
MC1R positive
Affiliated Hospitals
Clinical Trials Vincent Ma is currently running
IPH5201 + Durvalumab + Chemotherapy
for Lung Cancer
The study is intended to assess the safety and efficacy of neoadjuvant combination of IPH5201 and durvalumab in addition to standard chemotherapy and adjuvant combination of IPH5201 and durvalumab in untreated patients with resectable, early-stage (stage II to IIIA) non-small cell lung cancer (NSCLC).
Recruiting1 award Phase 211 criteria
Cemiplimab + Surgery
for Advanced Skin Cancer
This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may have come back after a period of improvement (recurrent). The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cemiplimab has been approved for the treatment of skin cancer that has spread or that cannot be removed by surgery, but it has not been approved for the treatment of skin cancer than can be removed by surgery. Adding cemiplimab to the usual treatment of surgery with or without radiation may be more effective in treating patients with stage III/IV resectable squamous cell skin cancer than the usual treatment alone.
Recruiting2 awards Phase 37 criteria
More about Vincent Ma
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Vincent Ma has experience with
- Pembrolizumab
- GD2-SADA:177Lu-DOTA Complex
- Durvalumab
- IPH5201
- Standard Chemotherapy
- Carboplatin
Breakdown of trials Vincent Ma has run
Skin Cancer
Melanoma
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vincent Ma specialize in?
Vincent Ma focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Vincent Ma currently recruiting for clinical trials?
Yes, Vincent Ma is currently recruiting for 6 clinical trials in Madison Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Vincent Ma has studied deeply?
Yes, Vincent Ma has studied treatments such as Pembrolizumab, GD2-SADA:177Lu-DOTA Complex, Durvalumab.
What is the best way to schedule an appointment with Vincent Ma?
Apply for one of the trials that Vincent Ma is conducting.
What is the office address of Vincent Ma?
The office of Vincent Ma is located at: University of Wisconsin Carbone Cancer Center, Madison, Wisconsin 53792 United States. This is the address for their practice at the University of Wisconsin Carbone Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.